- PR Newswire•7 days ago
Vermillion to Report Fourth Quarter and Full Year 2016 Financial Results and Host Investor Conference Call on March 29, 2017
AUSTIN, Texas, March 15, 2017 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its fourth quarter ...
- PR Newswire•16 days ago
ASPiRA LABs Announces Provider Status with Medi-Cal Expanding OVA1® Access to Over 12 Million Beneficiaries
AUSTIN, Texas, March 6, 2017 /PRNewswire/ -- ASPiRA LABs, a Vermillion company (NASDAQ: VRML), today announced it has attained out-of-state provider status with Medi-Cal, California's Medicaid program, ...
- PR Newswire•21 days ago
ASPiRA LABs Announces Contracted In-Network Agreement with Blue Cross Blue Shield of Michigan for OVA1®
AUSTIN, Texas, March 1, 2017 /PRNewswire/ -- ASPiRA LABs, a Vermillion company (NASDAQ: VRML), today announced a major contracted agreement with Blue Cross Blue Shield of Michigan for ASPiRA's U.S. FDA ...
VRML : Summary for Vermillion, Inc. - Yahoo Finance
Vermillion, Inc. (VRML)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.41 x 100|
|Ask||2.73 x 1000|
|Day's Range||2.03 - 2.16|
|52 Week Range||0.76 - 2.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.36|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|